
Genpharmasec Ltd Falls to 52-Week Low of Rs 0.79 as Sell-Off Deepens
2026-03-30 10:21:06For the second consecutive session, Genpharmasec Ltd has extended its decline, hitting a fresh 52-week low of Rs 0.79 on 30 Mar 2026, marking a 12.09% drop over two days amid broader market weakness.
Read full news article
Genpharmasec Ltd Falls to 52-Week Low Amid Continued Downtrend
2026-03-19 13:35:53Genpharmasec Ltd, a micro-cap player in the Trading & Distributors sector, has touched a new 52-week and all-time low of Rs.0.89 on 19 Mar 2026, marking a significant decline amid broader market weakness and sector underperformance.
Read full news article
Genpharmasec Ltd Stock Falls to 52-Week Low of Rs.0.91
2026-03-18 15:35:18Genpharmasec Ltd, a micro-cap player in the Trading & Distributors sector, has recorded a fresh 52-week and all-time low of Rs.0.91 today, marking a significant milestone in its ongoing price decline. The stock has underperformed its sector and benchmark indices, reflecting persistent challenges in its financial and market performance.
Read full news article
Genpharmasec Ltd is Rated Strong Sell
2026-03-17 10:10:17Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025, but the analysis below reflects the stock's current position as of 17 March 2026, incorporating the latest fundamentals, returns, and financial metrics.
Read full news article
Genpharmasec Ltd Stock Falls to 52-Week Low of Rs.0.94
2026-03-12 15:42:03Genpharmasec Ltd’s share price declined sharply to a new 52-week low of Rs.0.94 on 12 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. This fresh low reflects persistent pressures on the company’s valuation amid broader market weakness and company-specific financial factors.
Read full news article
Genpharmasec Ltd is Rated Strong Sell
2026-03-04 10:10:02Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Genpharmasec Ltd is Rated Strong Sell
2026-02-21 10:10:18Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news articleAre Genpharmasec Ltd latest results good or bad?
2026-02-10 19:23:08Genpharmasec Ltd's latest financial results for Q3 FY26 reveal significant operational challenges despite a remarkable surge in revenue. The company reported net sales of ₹39.83 crores, reflecting a substantial year-on-year growth of 369.69%. This marks the highest quarterly revenue in its recent history. However, this revenue growth has not translated into profitability, as the company posted a net loss of ₹0.83 crores, which is a stark contrast to the previous year's profit. The operating margin has turned negative at -3.09%, a drastic decline from the positive margin of 8.37% achieved in the same quarter last year. This indicates a troubling disconnect between revenue generation and cost management. The operating loss before other income was recorded at ₹1.23 crores, highlighting severe operational inefficiencies. Additionally, employee costs surged significantly, outpacing revenue growth, which raises ...
Read full news articleClosure of Trading Window
26-Mar-2026 | Source : BSEIntimation of closure of Trading window.
Outcome Of Separate Meeting Of Independent Directors Of The Company.
24-Mar-2026 | Source : BSEOutcome of Separate Meeting of Independent Directors held on March 24 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
11-Feb-2026 | Source : BSENewspaper Publication of Unaudited Financial Result for the quarter ended December 31 2025.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Genpharmasec Ltd has announced 1:10 stock split, ex-date: 11 Apr 19
No Bonus history available
Genpharmasec Ltd has announced 1:1 rights issue, ex-date: 09 Jan 24







